neoBLUE® cozy LED Phototherapy System
All the benefits of blue LED technology in a unique cradling design
The neoBLUE cozy system is positioned underneath the baby to deliver phototherapy via a blue LED light source.
Most Effective Degradation of Bilirubin1
Meets AAP guidelines for intensive phototherapy2
- Delivers intensive phototherapy for thousands of hours: > 30μ W/cm2/nm
- Emits blue light in the 450 - 470 nm spectrum - matching the peak absorption wavelength (458 nm) at which bilirubin is broken down1
- Exposes full length of baby from head to toe
- Delivers phototherapy over a larger area than standard phototherapy blankets or pads.
- neoBLUE LEDs do not emit light in the ultraviolet (UV) range - reducing the potential risk of skin damage
- neoBLUE LEDs do not emit light in the infrared radiation (IR) range - reducing the potential risk of fluid loss
- Device automatically shuts off in the event of elevated surface temperature
Designed for Comfort & Support
- Streamlined, oval design conforms to the shape of the baby
- Special neoPAD™ mattress provides comfortable cushioning underneath the infant
Ideal for Use in the Nursery or Mother's Room
- Fits easily within patient enclosures such as cribs, bassinets, and radiant warmers
|Our baby boy, Theo, was born at Denver Rose Medical Hospital on May 11th weighing a healthy 6lbs 8ozs. Although he is our second child, our anxiety was high when were told that his Bilirubin levels were higher than 'normal' at 10.7. Immediately the nurses said, we have a new Natus NeoBlue Cozy bed we're using that is much smaller, less intrusive and scary for babies and parents. We felt better - no lamps, no suits etc. After a day, Theo's Bilirubin level went down to 9 and the pediatrician was happy to send us home on Day 3. Theo didn't need any additional lights as we caught it early. We wanted to thank you all for a wonderful product that helped Theo and us recover quickly and safely! ~Connor Robinson||
1 Vreman HJ, et al. Light-emitting diodes: a novel light source for phototherapy. Pediatric Research. 1998; 44(5):804-809.
2 Subcommittee on Hyperbilirubinemia. American Academy of Pediatrics clinical practice guideline: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004; 114(1):297-316.